Valid from 1 January 2024
The following substances are considered PROHIBITED unless the player has obtained a Therapeutic Use Exemption in accordance with Article 4 of the ESIC Anti-Doping Policy
Generic substance listed followed by example brand name(s)
- Amphetamine sulfate (Evekeo)
- Dextroamphetamine (Adderall and Adderall XR),
- Dexedrine, (ProCentra, Zenzedi)
- Dexmethylphenidate (Focalin and Focalin XR)
- Lisdexamfetamine (Vyvanse)
- Methylphenidate (Concerta, Daytrana, Metadate CD and Metadate ER, Methylin and Methylin ER, Ritalin, Ritalin SR, Ritalin LA, Quillivant XR)
Players using these treatments for a justifiable medical condition must consult the Physician Guidelines with their prescribing Physician and compile a Medical File (update on medical review) in preparation for an application for a Therapeutic Use Exemption if an Adverse Finding is reported.